Cerebrospinal nerve growth factor - A marker of asphyxia?

Pediatric Neurology

Volumn 20, Issue 2, 1999, Pages 137-141

  Riikonen, Raili S ^a   Korhonen, Laura T ^a   Lindholm, Dan B ^a  

^a

^b Sweden

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR;

ARTICLE; ASPHYXIA; BRAIN HYPOXIA; BRAIN ISCHEMIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE GROWTH; NEUROTROPISM; NEWBORN; NEWBORN HYPOXIA; PRIORITY JOURNAL;

ADOLESCENT; ASPHYXIA NEONATORUM; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; NERVE GROWTH FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0033035346     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(98)00122-2     Document Type: Article

References (29)

1. Hope P., Costello A., Cady E., et al. Cerebral energy metabolism studied with phosphorus NMR spectroscopy in normal and birth-asphyxiated infants. Lancet. 18:1984;366-370.
2. Azzopardi D., Wyatt J., Cady E., et al. Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res. 25:1989;445-451.
3. Fellman V., Raivio K. Reperfusion injury as the mechanism of brain damage after perinatal asphyxia. Review article. Pediatr Res. 41:1997;599-606.
4. Mehmet H., Edwards A. Hypoxia, ischemia, and apoptosis. Arch Dis Child. 75:1996;F73-F75.
5. Holtzman D., Sheldon A., Jaffe W., Cheng W., Ferriero D. Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol. 39:1996;114-122.
6. Cheng Y., Gidday J., Yan Q., Shah A., Holtzman D. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann Neurol. 41:1997;521-529.
7. Lorigados L., Söderström S., Ebendal T. Two-site enzyme immunoassay for beta NGF applied to human patient sera. J Neurosci Res. 32:1992;329-339.
8. Lappalainen R., Lindholm D., Riikonen R. Low concentrations of nerve growth factor in cerebrospinal fluid of children with Rett syndrome. J Child Neurol. 11:1996;296-309.
9. Holmes G., Lombroso C. Prognostic value of background patterns in the neonatal EEG. J Clin Neurophysiol. 10:1993;323-352.
10. Hellström-Westas L., Rosen L., Svenningen N. Predictive value of early continuous amplitude integrated EEG recordings Outcome after severe birth asphyxia in full term infants . Arch Dis Child Fetal Neonatal Ed. 72:1995;F34-F38.
11. Thornberg E., Thiringer K., Hagberg H., Kjellmer I. Neuron specific enolase in asphyxiated newborns Association with encephalopathy and cerebral function monitoring . Arch Dis Child Fetal Neonatal Ed. 72:1995;F39-F42.
12. Sarnat H., Sarnat M. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 33:1976;696-705.
13. Riikonen R., Söderström S., Vanhala R., Ebendal T., Lindholm D. West's syndrome Cerebrospinal fluid nerve growth factor and effect of ACTH . Pediatr Neurol. 17:1997;224-229.
14. Riikonen R., Söderström S., Korhonen L., Lindholm D. Overstimulation of nerve growth factors in postinfectious and autoimmune diseases. Pediatr Neurol. 18:1998;231-235.
15. Laudiero L., Aloe L., Levi-Montalcini R., Schilter D., Gielssen S., Otten U. Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neurosci Lett. 147:1992;91-92.
16. Haddad J., Vilge V., Juif J., et al. Beta-nerve growth factor levels in newborn cord sera. Pediatr Res. 35:1994;637-639.
17. Aloe L., Skaper S., Leon A., Levi-Montalcini R. Nerve growth factor and autoimmune diseases. Autoimmunity. 19:1994;141-150.
18. Lindholm D., Castren E., Bergzaghi M., Blöchi A., Thoenen H. Activity-dependent and hormonal regulation of neurotrophin mRNA levels in the brain - Implications for neuronal plasticity. J Neurobiol. 25:1994;1362-1372.
19. Longo F., Selak I., Zovickian J., Manthrope M., Varon S., Hoi Sang U. Neurotrophic activities in cerebrospinal fluid of head trauma patients. Exp Neurol. 84:1984;207-218.
20. Patterson S., Grady M., Bothwell M. Nerve growth factor and a fibroblast growth factor-like activity in cerebrospinal fluid of brain injured human patients. Brain Res. 605:1993;43-49.
21. Shozuhara H., Onodera H., Katoh S., Yamasaki Y., Kogure K. Temporal profiles of nerve growth factor beta-subunit level in rat brain regions after transient ischemia. J Neurochem. 59:1992;175-180.
22. Mattson M., Murrain M., Guthrie P., Guthrie P., Kater S. Fibroblast growth factor and glutamate Opposing roles in the generation of hippocampal neuroarchitecture . J Neurosci. 9:1989;3728-3740.
23. Riikonen R., Kero P., Simell O. Excitatory amino acids in cerebrospinal asphyxia. Pediatr Neurol. 8:1992;37-40.
24. Hagberg H., Thornberg E., Blennow M., et al. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants Relationship to hypoxic-ischemic encephalopathy . Acta Paediatr. 82:1993;925-929.
25. Cheng B., Mattson M. NGF and βFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron. 7:1991;1031-1041.
26. Beck T., Lindholm D., Castren E., Wree A. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J Cereb Blood Flow Metab. 14:1994;689-692.
27. Gluckman P., Klempt N., Guan J., et al. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun. 182:1992;593-599.
28. Aloe L. Intracerebral pretreatment with nerve growth factor prevents irreversible brain lesions in neonatal rats injected with ibotenic acid. Biotechnology. 5:1987;1085-1086.
29. Volpe J. Hypoxic-ischemic encephalopathy Clinical aspects . Volpe J. Neurology of the newborn. 1995;314-369 Saunders, Philadelphia.